Management team

The management team is responsible for the day to day running of the charity.

Dave Tapolczay
Chief Executive Officer

Dave Tapolczay

Chief Executive Officer

Dave is LifeArc’s CEO. He has 28 years experience in R&D management and has been involved in the start-up of five companies, all of which are still trading.

+44 (0)20 7391 2700

Message Dave

Edward Bliss
General Counsel & Company Secretary

Edward Bliss

General Counsel & Company Secretary

General Counsel and Company Secretary. Edward also manages our Licensing team.

+ 44 (0) 207 391 2794

Message Edward

Justin Bryans
Executive Director, Drug Discovery

Justin Bryans

Executive Director, Drug Discovery

Justin runs our drug discovery and antibody engineering groups at the Centre for Therapeutics Discovery who work on small molecule and antibody projects.

+ 44 (0) 1438 544944

Message Justin

Amanda Cowley
Executive Director, Human Resources

Amanda Cowley

Executive Director, Human Resources

As the Head of HR,  Amanda  is responsible for leading the people agenda within Life Arc.

+ 44 (0)20 7391 2748

Message Amanda

Michael Dalrymple
Executive Director, Diagnostics & Science Foresight

Michael Dalrymple

Executive Director, Diagnostics & Science Foresight

Mike heads up the Centre for Diagnostics Development (CDD), LifeArc’s translational activity seeking to develop novel diagnostic tests from cutting edge basic research. In addition, Mike is leading the creation of a scientific foresighting function at LifeArc to identify future charitable investment areas in translation and runs a small scientific due diligence team that assists the company in new project assessment and acquisition.

+ 44 (0)20 7391 2776

Message Michael

Andrew Farquharson
Executive Director, Technology Transfer

Andrew Farquharson

Executive Director, Technology Transfer

Andrew leads the team responsible for identifying, protecting and progressing promising life science research to improve human health.

+44 (0) 207 391 2779

Message Andrew

Mike Johnson
Executive Director, Business Development

Mike Johnson

Executive Director, Business Development

Mike leads our Business Development and Marketing teams.  He is responsible for accessing projects to fill our drug discovery pipeline, licensing them out to industry partners and creating new models to deliver patient impact.

+ 44 (0) 20 7391 2825

Message Mike

Andrew Mercieca
Chief Financial Officer

Andrew Mercieca

Chief Financial Officer

Andrew manages our Finance department, and also oversees our ICT service.

+ 44 (0) 207 391 2781

Message Andrew

Business Development (BD)

Identifies and acquires projects and seeks commercial partners.

Mike Johnson
Executive Director, Business Development

Mike Johnson

Executive Director, Business Development

Mike leads our Business Development and Marketing teams.  He is responsible for accessing projects to fill our drug discovery pipeline, licensing them out to industry partners and creating new models to deliver patient impact.

+ 44 (0) 20 7391 2825

Message Mike

John Kelly
Head of BD, Therapeutics & Diagnostics

John Kelly

Head of BD, Therapeutics & Diagnostics

John heads a team responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.

+ 44(0) 143 854 4965

Message John

David Pardoe
Head of Innovation and Initiatives

David Pardoe

Head of Innovation and Initiatives

Dave is responsible for creating and implementing novel collaborative models across charity, industry, funder and academic partners that accelerate new therapies to patients.

+ 44 (0) 143 8544 084

Message David

Kevin Buchan
Business Development Manager

Kevin Buchan

Business Development Manager

Kevin is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.

+ 44 (0) 1438 544565

Message Kevin

Derek Sheader
Business Development Manager

Derek Sheader

Business Development Manager

Derek is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.

+ 44 (0) 143 854 4560

Message Derek

Meera Swami
Business Development Manager

Meera Swami

Business Development Manager

Meera is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry.

+ 44 (0) 1438 544087

Message Meera

Zhi Zhang
Business Development Manager

Zhi Zhang

Business Development Manager

Zhang is responsible for identifying early stage targets, small molecules and monoclonal antibodies for our drug discovery group and the licensing of mature programmes to industry, particularly in China.

+ 44 (0)20 7391 4096

Message Zhi

Opportunity Assessment Group

Researches and analyses the potential of new and existing biomedical opportunities.

Nicole Mathon
Principal, Opportunity Assessment Group

Nicole Mathon

Principal, Opportunity Assessment Group

Nicole co-manages the Opportunity Assessment Group which has responsibility for reviewing and assessing new and existing opportunities for LifeArc. The team assesses scientific/technical potential as well as undertaking competitive and market analysis.

+44 (0) 20 7391 2767

Message Nicole

Kerstin Papenfuss
Principal, Opportunity Assessment Group

Kerstin Papenfuss

Principal, Opportunity Assessment Group

Kerstin co-manages the Opportunity Assessment Group which has responsibility for reviewing and assessing new and existing opportunities for LifeArc. The team assesses scientific/technical potential as well as undertaking competitive and market analysis.

+44 (0) 20 7391 2813

Message Kerstin

Centre for Diagnostics Development (CDD)

Improves commercial readiness of early stage diagnostics from academic research.

Michael Dalrymple
Executive Director, Diagnostics & Science Foresight

Michael Dalrymple

Executive Director, Diagnostics & Science Foresight

Mike heads up the Centre for Diagnostics Development (CDD), LifeArc’s translational activity seeking to develop novel diagnostic tests from cutting edge basic research. In addition, Mike is leading the creation of a scientific foresighting function at LifeArc to identify future charitable investment areas in translation and runs a small scientific due diligence team that assists the company in new project assessment and acquisition.

+ 44 (0)20 7391 2776

Message Michael

Lorraine Anderson
Associate Director, Centre for Diagnostic Development

Lorraine Anderson

Associate Director, Centre for Diagnostic Development

Lorraine heads a team the Centre for Diagnostics Development (CDD), LifeArc’s translational activity seeking to develop novel diagnostic tests from cutting edge basic research.

+44 (0) 131 311 7011

Message Lorraine

Centre for Therapeutics Discovery (CTD)

Moving early stage molecular targets originating from academic research towards clinical benefit.

Justin Bryans
Executive Director, Drug Discovery

Justin Bryans

Executive Director, Drug Discovery

Justin runs our drug discovery and antibody engineering groups at the Centre for Therapeutics Discovery who work on small molecule and antibody projects.

+ 44 (0) 1438 544944

Message Justin

Katy Kettleborough
Associate Director, Biology

Katy Kettleborough

Associate Director, Biology

Katy is an Associate Director in LifeArc’s Centre for Therapeutics Discovery. She manages a team of biologists carrying out assay development and screening.

+ 44 (0) 1438 544966

Message Katy

David Matthews
Associate Director, BioTherapeutics

David Matthews

Associate Director, BioTherapeutics

David heads up the BioTherapeutics team. The group develops therapeutic antibodies, this includes antibody generation, humanisation, affinity maturation and biophysical characterisation of candidates.

+ 44 (0) 1438 544975

Message David

Andy Merritt
Associate Director, Chemistry

Andy Merritt

Associate Director, Chemistry

Andy manages a team of medicinal chemists who carry out early stage drug discovery, including hit-to-lead development at our Centre for Therapeutics Discovery.

+ 44 (0) 1438 544978

Message Andy

Technology Transfer (TT)

Identify, protect, develop and license research.

Andrew Farquharson
Executive Director, Technology Transfer

Andrew Farquharson

Executive Director, Technology Transfer

Andrew leads the team responsible for identifying, protecting and progressing promising life science research to improve human health.

+44 (0) 207 391 2779

Message Andrew

Mike Bond
Business Manager

Mike Bond

Business Manager

Mike covers LMB PNAC (shared), LMB Neurobiology (shared), Gambia, Uganda and CTSU.

+ 44 (0)20 7391 2727

Message Mike

Rachael Brooker
Business Manager

Rachael Brooker

Business Manager

Rachael covers LMB PNAC (shared) and IGMM – ECRC.

+ 44 (0)20 7391 7015

Message Rachael

Antonia Chatzopoulou
Business Manager

Antonia Chatzopoulou

Business Manager

Antonia is responsible for the MRC Institute of Hearing Research, the MRC Cognition & Brain Sciences Unit, the MRC Biostatistics Unit and the MRC Human Nutrition Research unit (shared).

+ 44 (0)20 7391 2754

Message Antonia

Georgia Gliki
Senior Business Manager

Georgia Gliki

Senior Business Manager

Georgia covers LMB Cell Biology, LMB PNAC (shared), LMB Neurobiology (shared) and MRC Mitchondrial Biology Unit (shared).

+ 44 (0) 1438 544956

Message Georgia

Sam Goldsmith
Business Manager

Sam Goldsmith

Business Manager

Sam covers LMB Neurobiology Division, Mammalian Genetics Unit,  Mary Lyons Centre (MRC Harwell).

+ 44 (0)20 7391 2750

Message Sam

Karen Law
Business Manager

Karen Law

Business Manager

Karen covers LMB Structural Studies, Human Nutrition Research unit (shared), LMB NMR Facility and MRC Mitochondrial Biology Unit (shared).

+ 44 (0) 1438 544077

Message Karen

Madhu Madhusudhan
Charity Sector Business Manager

Madhu Madhusudhan

Charity Sector Business Manager

Madhu looks after IP issues for our charity partners.

+ 44 (0)20 7391 2823

Message Madhu

Anji Miller
Senior Business Manager

Anji Miller

Senior Business Manager

Anji manages all IP, contractual and technology transfer matters arising from the MRC Prion Unit.

+44 (0)20 7391 2700

Message Anji

Steven Tait
Senior Business Manager

Steven Tait

Senior Business Manager

Steven covers Institute of Genetics and Molecular Medicine (MMC & HGU) and MRC Clincal Sciences Centre (shared).

+ 44 (0) 131 311 7024

Message Steven

Alex Templar
Business Manager

Alex Templar

Business Manager

Alex covers LMB Protein and Nucleic Acid Chemistry Division, MRC Molecular Haematology Unit and MRC Human Immunology Units at MRC WIMM.

+ 44 (0)20 7391 2762

Message Alex

Governance and Licencing

Negotiate and conclude all commercialisation and other agreements, General legal support for LifeArc business.

Edward Bliss
General Counsel & Company Secretary

Edward Bliss

General Counsel & Company Secretary

General Counsel and Company Secretary. Edward also manages our Licensing team.

+ 44 (0) 207 391 2794

Message Edward

Marketing & Communications

Coordinates the organisation's marketing and communications.

Jonathan McGee
Head of Marketing & Communications

Jonathan McGee

Head of Marketing & Communications

Jonathan leads our marketing and communications team to enable mutually beneficial relationships between LifeArc and its customers.

+ 44 (0) 1438 544 082

Message Jonathan

Liezel Tipper
PR & Communications Manager

Liezel Tipper

PR & Communications Manager

Liezel manages media relations, internal and external communications.

+ 44 (0)20 7391 2772

Message Liezel

Finance

Manages the organisation's long-term and day-to-day monetary operations and strategy.

Andrew Mercieca
Chief Financial Officer

Andrew Mercieca

Chief Financial Officer

Andrew manages our Finance department, and also oversees our ICT service.

+ 44 (0) 207 391 2781

Message Andrew

Mimi Ray
Finance

Mimi Ray

Finance

For any finance enquiries please contact Mimi Ray at accountsenquiries@lifearc.org

+ 44 (0)20 7391 2782

Message Mimi

ICT

The organisation's information technology department plans, operates and supports IT infrastructure.

Paul Clutten
Associate Director, ICT

Paul Clutten

Associate Director, ICT

Paul heads ICT team.

+ 44 (0) 1438 544967

Message Paul